Charles River Laboratories International Inc 2019 SR
The report is the inaugural 2019 Corporate Citizenship Report for Charles River Laboratories, a contract research organization. It highlights the company's commitment to ESG transparency, including a goal to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50.4% by 2030. In 2019, the company supported 85% of FDA-approved drugs and achieved a 23% reduction in global GHG emissions from the previous year. The report also details initiatives in animal welfare, diversity and inclusion, and community involvement, such as packaging 1.2 million meals for global food aid.
Company: Charles River Laboratories International Inc
Sector: Professional & technical services
Country: United States
Year: 2019
Type: SR
Pages: 42
Charles River Laboratories International Inc
The report is the inaugural 2019 Corporate Citizenship Report for Charles River Laboratories, a contract research organization. It highlights the company's commitment to ESG transparency, including a goal to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50.4% by 2030. In 2019, the company supported 85% of FDA-approved drugs and achieved a 23% reduction in global GHG emissions from the previous year. The report also details initiatives in animal welfare, diversity and inclusion, and community involvement, such as packaging 1.2 million meals for global food aid.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 1, 2019 - Dec 31, 2019
Fiscal Year
2019
Published
Nov 1, 2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Women on Board
Women in Management
Workplace Fatalities
Employees